Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_provenance.
- NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_assertion description "[For example, systemic delivery of recombinant ES to rat insulin promoter 1 (Rip1)T-antigen 2 (Tag2)-transgenic mice, a mouse model of pancreatic beta-cell carcinogenesis, has repressed tumor angiogenesis efficiently and with it, tumor growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_provenance.
- NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_assertion evidence source_evidence_literature NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_provenance.
- NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_assertion SIO_000772 16793908 NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_provenance.
- NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_assertion wasDerivedFrom befree-20150227 NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_provenance.
- NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_assertion wasGeneratedBy ECO_0000203 NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP767147.RACGhOe5UGkmpIb1_mu_4b3tMMOPuEnGu2F-GzA6F2HHc130_provenance.